GLPGF
Lakefront Biotherapeutics NV
Key Financials
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 424B3 | 5/8/2026 | View on SEC |
| 6-K | 5/6/2026 | View on SEC |
| 6-K | 4/29/2026 | View on SEC |
| 6-K | 3/31/2026 | View on SEC |
| 6-K | 3/30/2026 | View on SEC |
| 20-F | 3/26/2026 | View on SEC |
| 6-K | 3/24/2026 | View on SEC |
| 6-K | 3/17/2026 | View on SEC |
| 6-K | 3/10/2026 | View on SEC |
| 6-K | 3/6/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | GLPGF |
| Company Name | Lakefront Biotherapeutics NV |
| CIK | 1421876 |
| Sector | Pharmaceutical Preparations |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | other |
| State of Incorporation | C9 |
| Phone | 3215342900 |